Vanguard Fiduciary Trust’s Arcadia Biosciences RKDA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,394	Closed	-$6.06K	–	4136
2026 Q1	$6.06K	Buy	+4,394	New	+$8.61K	﹤0.01%	4023

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Fiduciary Trust's RKDA Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of Arcadia Biosciences (RKDA) in Q2 2026, closing a stake of 4,394 shares — an estimated $6.06K sold.

Vanguard Fiduciary Trust first reported a position in RKDA in Q1 2026 and held it in 1 quarter. The position peaked at $6.06K in Q1 2026. 17 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

Vanguard Fiduciary Trust reported no remaining Arcadia Biosciences position as of Q2 2026 after selling out during the quarter.
Vanguard Fiduciary Trust sold 4,394 Arcadia Biosciences shares in Q2 2026, an estimated $6.06K.
Vanguard Fiduciary Trust first reported a position in Arcadia Biosciences in Q1 2026 and held it in 1 quarter.
Vanguard Fiduciary Trust's Arcadia Biosciences position peaked at $6.06K in Q1 2026.
17 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.